| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Neoplasm | 14 | 2024 | 1580 | 2.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 12 | 2021 | 1655 | 1.790 |
Why?
|
| Melanoma | 21 | 2021 | 5595 | 1.560 |
Why?
|
| Dendritic Cells | 10 | 2012 | 1110 | 1.550 |
Why?
|
| Cancer Vaccines | 10 | 2024 | 754 | 1.450 |
Why?
|
| Melanoma, Experimental | 6 | 2021 | 382 | 1.420 |
Why?
|
| T-Lymphocytes | 16 | 2024 | 3949 | 1.390 |
Why?
|
| Immunotherapy, Adoptive | 8 | 2021 | 1840 | 1.360 |
Why?
|
| Proto-Oncogene Proteins B-raf | 6 | 2014 | 1336 | 0.910 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 5 | 2019 | 1032 | 0.900 |
Why?
|
| T-Lymphocytes, Cytotoxic | 10 | 2012 | 1020 | 0.900 |
Why?
|
| Antigen Presentation | 6 | 2018 | 286 | 0.860 |
Why?
|
| Adoptive Transfer | 4 | 2016 | 431 | 0.860 |
Why?
|
| Immunotherapy | 13 | 2023 | 3557 | 0.730 |
Why?
|
| Neoplasms | 12 | 2024 | 15927 | 0.660 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2013 | 1051 | 0.650 |
Why?
|
| Neoplasms, Experimental | 3 | 2012 | 784 | 0.620 |
Why?
|
| Interleukin-1alpha | 2 | 2021 | 53 | 0.590 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 2024 | 1137 | 0.560 |
Why?
|
| Lentivirus | 3 | 2011 | 164 | 0.520 |
Why?
|
| Immune System | 2 | 2018 | 275 | 0.510 |
Why?
|
| Interferon-gamma | 4 | 2012 | 1179 | 0.500 |
Why?
|
| Tumor Microenvironment | 8 | 2024 | 3035 | 0.490 |
Why?
|
| Melanoma-Specific Antigens | 2 | 2013 | 84 | 0.480 |
Why?
|
| Oximes | 2 | 2013 | 191 | 0.470 |
Why?
|
| Chemokines | 2 | 2012 | 290 | 0.470 |
Why?
|
| Epitopes | 4 | 2018 | 707 | 0.430 |
Why?
|
| Indoles | 3 | 2013 | 1028 | 0.430 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2011 | 290 | 0.420 |
Why?
|
| Mastocytoma | 1 | 2012 | 6 | 0.420 |
Why?
|
| Flow Cytometry | 6 | 2012 | 3045 | 0.420 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2012 | 294 | 0.400 |
Why?
|
| Histocompatibility Antigens Class I | 4 | 2016 | 247 | 0.400 |
Why?
|
| Precision Medicine | 2 | 2017 | 1207 | 0.400 |
Why?
|
| Cytoplasm | 2 | 2011 | 702 | 0.390 |
Why?
|
| CD40 Antigens | 1 | 2012 | 106 | 0.380 |
Why?
|
| Drug Administration Routes | 1 | 2011 | 60 | 0.380 |
Why?
|
| Genes, MHC Class I | 2 | 2008 | 50 | 0.380 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 294 | 0.370 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2010 | 58 | 0.360 |
Why?
|
| HLA Antigens | 3 | 2018 | 594 | 0.360 |
Why?
|
| Interleukin-1 | 1 | 2011 | 475 | 0.350 |
Why?
|
| Receptors, OX40 | 3 | 2019 | 51 | 0.340 |
Why?
|
| Imidazoles | 2 | 2013 | 1065 | 0.340 |
Why?
|
| Sulfonamides | 4 | 2013 | 1933 | 0.340 |
Why?
|
| Cell Separation | 2 | 2010 | 609 | 0.330 |
Why?
|
| Cell Line, Tumor | 16 | 2024 | 14849 | 0.330 |
Why?
|
| Lysosomes | 3 | 2012 | 345 | 0.330 |
Why?
|
| Antibodies | 1 | 2012 | 809 | 0.330 |
Why?
|
| Cross-Priming | 2 | 2012 | 40 | 0.330 |
Why?
|
| Skin Neoplasms | 4 | 2012 | 4895 | 0.320 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 593 | 0.320 |
Why?
|
| Interleukin-7 | 2 | 2013 | 92 | 0.310 |
Why?
|
| Tumor Escape | 2 | 2023 | 247 | 0.310 |
Why?
|
| Animals | 24 | 2023 | 61956 | 0.310 |
Why?
|
| Thiazoles | 1 | 2012 | 723 | 0.310 |
Why?
|
| Mice | 19 | 2023 | 35600 | 0.310 |
Why?
|
| Alternative Splicing | 1 | 2011 | 611 | 0.300 |
Why?
|
| Genetic Vectors | 2 | 2004 | 1857 | 0.300 |
Why?
|
| Endosomes | 1 | 2008 | 105 | 0.300 |
Why?
|
| Endocytosis | 2 | 2008 | 232 | 0.300 |
Why?
|
| Cell Movement | 2 | 2012 | 2472 | 0.290 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2024 | 5574 | 0.290 |
Why?
|
| Antigen-Presenting Cells | 3 | 2024 | 286 | 0.290 |
Why?
|
| Cell Proliferation | 8 | 2013 | 7238 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2007 | 185 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 3597 | 0.270 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2012 | 714 | 0.270 |
Why?
|
| Humans | 49 | 2024 | 270740 | 0.270 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2012 | 1097 | 0.260 |
Why?
|
| gp100 Melanoma Antigen | 4 | 2013 | 94 | 0.260 |
Why?
|
| Neoplasm Proteins | 8 | 2016 | 3345 | 0.260 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 9042 | 0.250 |
Why?
|
| Antibodies, Monoclonal | 2 | 2023 | 4481 | 0.250 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 965 | 0.250 |
Why?
|
| Interleukins | 1 | 2007 | 341 | 0.250 |
Why?
|
| Cathepsin G | 2 | 2016 | 22 | 0.240 |
Why?
|
| Immunological Synapses | 1 | 2024 | 31 | 0.240 |
Why?
|
| Transgenes | 2 | 2004 | 576 | 0.230 |
Why?
|
| MART-1 Antigen | 3 | 2010 | 113 | 0.230 |
Why?
|
| Lymphocyte Activation | 4 | 2012 | 1723 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 85 | 0.230 |
Why?
|
| Mice, Transgenic | 5 | 2012 | 4223 | 0.220 |
Why?
|
| Frameshift Mutation | 1 | 2024 | 234 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2023 | 7100 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 1281 | 0.210 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 12033 | 0.200 |
Why?
|
| Pyrimidines | 2 | 2012 | 3669 | 0.200 |
Why?
|
| Mutation | 8 | 2024 | 15912 | 0.200 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2018 | 683 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 3917 | 0.180 |
Why?
|
| Cell Differentiation | 1 | 2012 | 4116 | 0.180 |
Why?
|
| Transduction, Genetic | 3 | 2010 | 494 | 0.180 |
Why?
|
| HLA-A2 Antigen | 3 | 2012 | 172 | 0.180 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2024 | 481 | 0.170 |
Why?
|
| Tumor Burden | 4 | 2017 | 2033 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2011 | 81 | 0.170 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2019 | 101 | 0.160 |
Why?
|
| Colitis | 1 | 2022 | 341 | 0.160 |
Why?
|
| Interleukin-2 | 2 | 2012 | 889 | 0.160 |
Why?
|
| Chromatin | 1 | 2024 | 1046 | 0.160 |
Why?
|
| RNA Editing | 1 | 2018 | 97 | 0.150 |
Why?
|
| Ipilimumab | 2 | 2024 | 764 | 0.150 |
Why?
|
| Biomarkers, Tumor | 2 | 2016 | 10708 | 0.150 |
Why?
|
| Immunity, Cellular | 2 | 2012 | 440 | 0.140 |
Why?
|
| Membrane Glycoproteins | 3 | 2008 | 1094 | 0.140 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2017 | 191 | 0.130 |
Why?
|
| Cell Line | 3 | 2012 | 5338 | 0.130 |
Why?
|
| Amino Acid Motifs | 2 | 2008 | 399 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2018 | 5694 | 0.120 |
Why?
|
| Cell Survival | 2 | 2011 | 3063 | 0.120 |
Why?
|
| Integrin alpha4beta1 | 1 | 2014 | 46 | 0.120 |
Why?
|
| Cytokines | 4 | 2021 | 2825 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 3 | 2012 | 5759 | 0.120 |
Why?
|
| Down-Regulation | 2 | 2011 | 2090 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1012 | 0.110 |
Why?
|
| Pyrimidinones | 2 | 2013 | 318 | 0.110 |
Why?
|
| Pyridones | 2 | 2013 | 360 | 0.110 |
Why?
|
| Triazoles | 1 | 2017 | 627 | 0.110 |
Why?
|
| Leuprolide | 1 | 2013 | 66 | 0.110 |
Why?
|
| Myeloid Cells | 2 | 2022 | 273 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2014 | 295 | 0.110 |
Why?
|
| Mice, Inbred DBA | 1 | 2012 | 117 | 0.100 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 300 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2023 | 1776 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2021 | 2375 | 0.100 |
Why?
|
| Vaccines, Subunit | 1 | 2013 | 128 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2012 | 40 | 0.100 |
Why?
|
| Lymphocyte Subsets | 1 | 2012 | 138 | 0.100 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 53 | 0.100 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2012 | 30 | 0.100 |
Why?
|
| CD57 Antigens | 1 | 2012 | 22 | 0.100 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 161 | 0.100 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 1111 | 0.100 |
Why?
|
| B7-1 Antigen | 1 | 2012 | 84 | 0.100 |
Why?
|
| Myeloblastin | 1 | 2012 | 65 | 0.100 |
Why?
|
| Leukocyte Elastase | 1 | 2012 | 71 | 0.100 |
Why?
|
| Molecular Sequence Data | 3 | 2010 | 6685 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 3216 | 0.100 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2011 | 18 | 0.100 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2011 | 36 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 693 | 0.100 |
Why?
|
| Peptides | 2 | 2018 | 1504 | 0.100 |
Why?
|
| Melanocytes | 1 | 2012 | 240 | 0.090 |
Why?
|
| Chemokine CCL5 | 1 | 2011 | 76 | 0.090 |
Why?
|
| Chemokine CXCL10 | 1 | 2011 | 106 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2013 | 6390 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2014 | 486 | 0.090 |
Why?
|
| Chemokine CXCL1 | 1 | 2010 | 67 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2017 | 2422 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 1121 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2012 | 484 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 563 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 382 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2004 | 1685 | 0.090 |
Why?
|
| Female | 15 | 2024 | 148940 | 0.090 |
Why?
|
| Uveal Neoplasms | 1 | 2012 | 194 | 0.090 |
Why?
|
| Trans-Activators | 1 | 2016 | 1624 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2012 | 380 | 0.090 |
Why?
|
| Luciferases | 1 | 2010 | 460 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 16689 | 0.080 |
Why?
|
| Protein Binding | 2 | 2012 | 3485 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 714 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2012 | 1356 | 0.080 |
Why?
|
| Middle Aged | 8 | 2024 | 90352 | 0.080 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1199 | 0.080 |
Why?
|
| Lymphoma | 2 | 2007 | 1519 | 0.080 |
Why?
|
| Vacuoles | 1 | 2008 | 47 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 4961 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 30998 | 0.080 |
Why?
|
| Dasatinib | 1 | 2012 | 881 | 0.080 |
Why?
|
| Stromal Cells | 1 | 2012 | 825 | 0.080 |
Why?
|
| Neoplasm Staging | 3 | 2013 | 14012 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 14617 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2011 | 909 | 0.080 |
Why?
|
| OX40 Ligand | 1 | 2008 | 23 | 0.080 |
Why?
|
| Tumor Necrosis Factors | 1 | 2008 | 34 | 0.080 |
Why?
|
| Receptors, CCR5 | 1 | 2008 | 55 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 968 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 2 | 2016 | 2399 | 0.070 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2007 | 49 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2012 | 840 | 0.070 |
Why?
|
| Exons | 1 | 2011 | 1383 | 0.070 |
Why?
|
| Male | 10 | 2024 | 128315 | 0.070 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2007 | 170 | 0.070 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 163 | 0.070 |
Why?
|
| Vaccines, DNA | 1 | 2007 | 111 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2013 | 3584 | 0.070 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2006 | 85 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5408 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 3530 | 0.070 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 316 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 1580 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 469 | 0.070 |
Why?
|
| Transfection | 1 | 2011 | 3117 | 0.070 |
Why?
|
| HLA-A Antigens | 1 | 2006 | 105 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2007 | 259 | 0.070 |
Why?
|
| Clone Cells | 1 | 2007 | 591 | 0.070 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2006 | 105 | 0.070 |
Why?
|
| Heterografts | 2 | 2019 | 738 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 73333 | 0.060 |
Why?
|
| Antigens, CD1 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 1472 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 7265 | 0.060 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 530 | 0.060 |
Why?
|
| Histocompatibility Testing | 1 | 2006 | 487 | 0.060 |
Why?
|
| HLA-DP beta-Chains | 1 | 2004 | 16 | 0.060 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2024 | 64 | 0.060 |
Why?
|
| HLA-DP Antigens | 1 | 2004 | 20 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2005 | 189 | 0.060 |
Why?
|
| HLA-DQ beta-Chains | 1 | 2004 | 34 | 0.060 |
Why?
|
| Monophenol Monooxygenase | 1 | 2004 | 60 | 0.060 |
Why?
|
| HLA-DQ Antigens | 1 | 2004 | 56 | 0.060 |
Why?
|
| Chemokine CX3CL1 | 1 | 2023 | 10 | 0.060 |
Why?
|
| HLA-DRB1 Chains | 1 | 2004 | 89 | 0.060 |
Why?
|
| NFATC Transcription Factors | 1 | 2024 | 96 | 0.060 |
Why?
|
| HLA-DR Antigens | 1 | 2004 | 184 | 0.060 |
Why?
|
| Cell Transformation, Viral | 1 | 2004 | 174 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2021 | 33737 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2004 | 130 | 0.060 |
Why?
|
| Hepatitis Viruses | 1 | 2003 | 6 | 0.060 |
Why?
|
| Genes, Regulator | 1 | 2003 | 81 | 0.050 |
Why?
|
| Leukemia | 1 | 2012 | 1719 | 0.050 |
Why?
|
| Virus Integration | 1 | 2003 | 73 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2012 | 1424 | 0.050 |
Why?
|
| Gene Library | 1 | 2024 | 353 | 0.050 |
Why?
|
| Cell Line, Transformed | 1 | 2003 | 427 | 0.050 |
Why?
|
| Human papillomavirus 16 | 1 | 2024 | 255 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2007 | 1418 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2012 | 5728 | 0.050 |
Why?
|
| Virion | 1 | 2003 | 186 | 0.050 |
Why?
|
| Tyrosine | 1 | 2003 | 508 | 0.050 |
Why?
|
| Adult | 6 | 2024 | 82040 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 3640 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2024 | 627 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2003 | 339 | 0.050 |
Why?
|
| DNA Mismatch Repair | 1 | 2024 | 283 | 0.050 |
Why?
|
| Microsatellite Instability | 1 | 2024 | 408 | 0.050 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2024 | 295 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 2518 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 376 | 0.050 |
Why?
|
| Apoptosis | 2 | 2013 | 7757 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2016 | 593 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2013 | 485 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 2069 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2004 | 804 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2003 | 491 | 0.050 |
Why?
|
| Vaccination | 1 | 2006 | 1166 | 0.040 |
Why?
|
| Phenotype | 1 | 2012 | 6509 | 0.040 |
Why?
|
| Monocytes | 1 | 2004 | 790 | 0.040 |
Why?
|
| Protein Transport | 2 | 2012 | 737 | 0.040 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 103 | 0.040 |
Why?
|
| Disease Progression | 1 | 2011 | 6867 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 22505 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2004 | 961 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2021 | 6256 | 0.040 |
Why?
|
| Piperazines | 1 | 2008 | 2145 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 7381 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 2 | 2007 | 5257 | 0.040 |
Why?
|
| Cyclin I | 1 | 2018 | 8 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2004 | 1309 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2019 | 247 | 0.040 |
Why?
|
| Immunologic Factors | 1 | 2022 | 672 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 4567 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 1050 | 0.040 |
Why?
|
| Proteogenomics | 1 | 2018 | 110 | 0.040 |
Why?
|
| Alleles | 1 | 2004 | 2600 | 0.040 |
Why?
|
| Young Adult | 2 | 2013 | 22251 | 0.030 |
Why?
|
| Neutrophils | 1 | 2021 | 873 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 2573 | 0.030 |
Why?
|
| Models, Biological | 1 | 2005 | 3194 | 0.030 |
Why?
|
| Signal Transduction | 4 | 2021 | 12103 | 0.030 |
Why?
|
| Interferons | 1 | 2017 | 299 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2016 | 189 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2016 | 262 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 2359 | 0.030 |
Why?
|
| Receptors, Vitronectin | 1 | 2014 | 28 | 0.030 |
Why?
|
| Shear Strength | 1 | 2014 | 30 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2024 | 5315 | 0.030 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2014 | 73 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 123 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2014 | 319 | 0.030 |
Why?
|
| Colorectal Neoplasms | 2 | 2024 | 3707 | 0.030 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1993 | 48 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1993 | 101 | 0.030 |
Why?
|
| Niacinamide | 1 | 2014 | 428 | 0.030 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 51 | 0.030 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2012 | 149 | 0.030 |
Why?
|
| Immunocompetence | 1 | 2012 | 73 | 0.020 |
Why?
|
| Adolescent | 2 | 2012 | 32767 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2014 | 1028 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1076 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 640 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 600 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2024 | 5438 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 685 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2012 | 579 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 827 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 550 | 0.020 |
Why?
|
| Pyridazines | 1 | 2012 | 324 | 0.020 |
Why?
|
| Quinolines | 1 | 2012 | 402 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 841 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 2067 | 0.020 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2007 | 202 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 757 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 1584 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 2137 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 3656 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 3046 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 1367 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 1710 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 5149 | 0.020 |
Why?
|
| Asthma | 1 | 1993 | 895 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 1942 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 5056 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2008 | 1691 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2006 | 1525 | 0.010 |
Why?
|
| Benzamides | 1 | 2008 | 1879 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 2454 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2007 | 1275 | 0.010 |
Why?
|
| Lung | 1 | 1993 | 3298 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2012 | 9292 | 0.010 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 1894 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 9039 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 10265 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 3476 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 5437 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2007 | 1718 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 7044 | 0.010 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 1993 | 23 | 0.010 |
Why?
|
| DNA Probes | 1 | 1993 | 247 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1993 | 453 | 0.010 |
Why?
|
| Autopsy | 1 | 1993 | 170 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1993 | 726 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 1133 | 0.010 |
Why?
|
| RNA | 1 | 1993 | 1063 | 0.000 |
Why?
|
| DNA | 1 | 1993 | 3050 | 0.000 |
Why?
|
| Smoking | 1 | 1993 | 2555 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1993 | 17061 | 0.000 |
Why?
|